medigraphic.com
Asociación Mexicana de Gastroenterología

2005, Number 1

<< Back Next >>

Rev Gastroenterol Mex 2005; 70 (1)

Prevalence of Barrett’s esophagus in non-selected patients submitted to esophagogastroduodenoscopy and associated risk factors

Gómez PAN, Manrique MA, Chávez GMA, Pérez VE, Ladrón DL, López GJ

Language: Spanish
References: 18
Page: 20-24
PDF size: 46.48 Kb.


ABSTRACT

Objetive: To establish the prevalence of the Barrett esophagus (BE) in non-selected patients who underwent upper gastrointestinal endoscopy (UGE) and identified risk factors associated. Methods: Case-control study on patients who underwent UGE between 2001-2003. Demographic data was gathered as well as the presence of esophagitis, H. pylori, hiatal hernia presence and length, nighttime symptoms, smoking, and alcohol consumption. Results: The global frequency of EB was 0.26%. Average age in patients with EB was 57.3 ± 17 years old against 49 ± 15 years old on the control group (p = 0.16). 69% of the patients with EB were men compared to 56% on the control group (p = 0.41). No difference regarding the presence of hiatal hernia was found between EB (79.6%) and patients without EB (72.5%) (p = 0.75). However, patients with EB presented a longer hiatal hernia (p ‹ 0.05). There was no difference regarding the presence of esophagitis (p = 0.32), H. pylori (p = 0.61), smoking (p = 0.39), alcohol consumption (p = 0.34), nocturnal symptoms (p = 0.53) or extra-esophageal manifestations (p = 0.31). A significant difference existed regarding the presence of heartburn and the length of symptoms: patients with EB stated a history longer than 5 years in comparison with the control group (p ‹ 0.005 and ‹ 0.01 respectively). Conclusions: The frequency of EB was 0.26% in Mexican non-selected population; the extents of hiatal hernia and history heartburn as well as a longer duration of symptoms were significantly associated to EB.


REFERENCES

  1. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997; 26: 487-94.

  2. Boulton RA, Usselmann B, Mohammed I, Jankowski J. Barrett’s esophagus: environmental influences in the progression of dysplasia. World J Surg 2003; 27: 1014-7.

  3. Pera M. Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg 2003; 27: 999-1008.

  4. Eisen GM, Sandler RS, Murray S. Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett’s esophagus. Am J Gastroenterol 1997; 92: 27-31.

  5. Okamoto K, Iwakiri R, Mori M. Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig Dis Sci 2003; 48: 2237-41.

  6. Wong M, Lai K, Lam K, et al. Onset and disappearance of reflux symptoms in a Chinese population: 1 year follow-up study. Alimen Pharmacol Ther 2004; 20: 803-12.

  7. El-Serag H, Petersen N, Carter J. Gastroesophageal Reflux among different racial groups in the Unites States. Gastroenterology 2004; 126: 1692-9.

  8. DeVault K. Extraesophageal symptoms of GERD. Clev Clin J Med 2003; 70: S20-32.

  9. Winters CJr, Spurling TJ, Chobanian SJ, et al. Barrett’s esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92(1): 118-24.

  10. Eloubeidi Ma, Provenzale D. Clinical and demographic predictors of barrett’s esophagus among patients with gastroesophageal reflux disease. J Clin Gastroenterol 2001; 33: 306-9.

  11. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Hiatal hernia and acid reflux frequency predict presence and length of barrett’s esophagus. Dig Dis Sci 2002; 47: 256-64.

  12. Conio M, Filiberti R, Blanchi S, et al. Risk factors for barrett’s esophagus: a case control study. Int J Cancer 2002; 97: 225-9.

  13. Fountoulakis A, Zafirellis KD, Dolan K, et al. Effect of surveillance of Barrett’s oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 2004; 91: 997-1003.

  14. Bersentes K, Fass R, Padda S, et al. Prevalence of Barrett’s esophagus in hispanics is similar to caucasians. Dis Dis Sci 1998; 43: 1038-41.

  15. Kamberoglou DK, Savva SC, Kalapothakos PN, et al. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction. Hepatogastroenterology 2002; 49: 995-8.

  16. Cameron AJ. Barrett’s esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 1999; 94: 2054-9.

  17. Lieberman DA, Oehlke M, Helfand M. Risk factors for Barret’s esophagus in community-based practice. Gorge consortium. Gastroenterology outcomes research group in endoscopy. Am J Gastroenterol 1997; 92: 1293-7.

  18. Uscanga L, Nogueira-de-Rojas JR, Gallardo E, et al. Gastroesophageal reflux disease. Gastroenterology mexican association consensus. Mexican group for the gerd study. Rev Gastroenterol Mex 2002; 67: 216-23.




2020     |     www.medigraphic.com